Pharmaceutical Contract Manufacturing Global market is expected to be $100,102.8 million by 2030

BENGALURU, India - Sept. 29, 2023 - PRLog -- Pharmaceutical Contract Manufacturing (PCM) – Forecast to 2030 is estimated to be worth $100,102.8 million by 2030

Pharmaceutical Contract Manufacturing (PCM) Global Market, Based on Product:

• API Manufacturing
• Branded API Manufacturing
• Generic API Manufacturing
• Finished dosage form (FDF) Manufacturing
• Solid Dosage Forms
• Tablets
• Capsules
• Others (Powders and Granules)
• Injectables Dosage Forms
• Semisolid, Liquid and Gaseous Dosage Forms

Pharmaceutical Contract Manufacturing (PCM) Global Market, Based on Phase

• Clinical Manufacturing
• Commercial Manufacturing

Pharmaceutical Contract Manufacturing (PCM) Global Market, Based on Application

• Oncology
• Central Nervous System
• Cardiovascular Diseases
• Infectious Diseases
• Pulmonary Diseases
• Metabolic Diseases
• Gastrointestinal Diseases
• Musculoskeletal Diseases
• Genitourinary Diseases
• Endocrine Diseases
• Other Applications

Pharmaceutical Contract Manufacturing (PCM) Global Market, Based on Geography:

• North America (U.S. and Rest of NA)
• Europe (Germany, France, Italy, and Rest of Europe)
• Asia-Pacific (China, India, Japan, and Rest of APAC)
• Rest of World (Brazil, Rest of Latin America and Middle East and Others)

Website: https://www.iq4i.com

Report link: https://iq4i.com/report-store/

Email: bd@iq4i.com, satish.birudukota@iq4i.com,

Phone: +91-9886722024, 8147030229,